Understanding immunoregulatory mechanisms is essential for the development of novel
interventions to improve long-term allograft survival. Programmed death 1 (PD-1) and its …

Over the past century, solid organ transplantation has been improved both at a surgical and
postoperative level. However, despite the improvement in efficiency, safety, and survival, we …

Over a half century, organ transplantation has become an effective method for the treatment
of end-stage visceral diseases. Although the application of immunosuppressants (IS) …

Immune checkpoint molecules such as programmed death-1 (PD-1) and programmed death
ligand-1 (PD-L1) have revolutionized the field of lung cancer treatment. As part of our study …

Oleoylethanolamide (OEA) is an endogenous lipid mediator involved in the control of
feeding, body weight, and energy metabolism. However, whether OEA modulates …

Cancer is a common complication after kidney transplantation. Kidney transplant recipients
(KTR) have a 2-to 4-fold higher risk of developing cancer compared to the general …

Dendritic cells (DCs) have a critical effect on the outcome of adaptive immune responses
against growing tumors. Tumor-infiltrating dendritic cells (TIDCs) play diverse roles in the …

Organ transplantation is the optimal treatment for patients with end‐stage diseases. T cell
activation is a major contributing factor toward the trigger of rejection. Induction therapy with …

The balance of effector and regulatory mechanisms contributing to allograft outcome is very
complex. It is likely that targeting multiple pathways will be required to achieve tolerance …

Objective The aim of this study was to systematically review the effects of transfusing Tol‐
DCs induced by different methods on renal transplantation and survival time. Method …